Discussion == After publication of the XMRV study by Lombardi et al. virus-related computer virus (XMRV) is usually a recently discovered gammaretrovirus reportedly associated with prostate malignancy and chronic fatigue syndrome (CFS) [1,2]. The discovery of XMRV arose from studies investigating a potential viral cause for diseases in patients with anRNAseLgene variant. This genotype, which is observed in a varying subset of patients in cohorts with prostate cancer [1,38], has been associated with impairment of innate immune responses to viral infections [5]. Seeking an etiologically significant viral infection associated with impairedRNAse L-dependent responses, Urisman et al. first identified XMRV in 2006 in a cohort of prostate cancer patients [2]. The association of XMRV with prostate cancer, but not its association with theRNAseLvariant, was corroborated by Schlaberg et al. in 2009 2009 [9]. The prostate cancer studies were followed by a report from Lombardi et al. presenting evidence for XMRV infection in 67% of individuals with severe CFS, compared to 3.7% of healthy MC-976 individuals [1]. These high reported frequencies of XMRV infection and putative linkage to a debilitating illness prompted concerns about the possibility of a new, widespread retroviral epidemic and stimulated additional research towards determining the prevalence MC-976 of XMRV infection in different populations worldwide. Several studies supporting high prevalence of XMRV infection followed. For example, Arnold et al. detected anti-XMRV antibodies in 27% of individuals with prostate cancer [10], Schlaberg et al. found XMRV nucleic acid in 23% of prostate cancers and 4% of controls [11], and Danielson et al. detected XMRV in 22.8% of extracted prostate tissues from individuals who had radical prostatectomies [12]. However, controversy arose when other laboratories could not demonstrate comparable findings in similar cohorts not only in the US [13] but in Germany [14], The Netherlands [15], and England [16,17]. Adding to the controversy, Lo et al. reported the presence of mouse retroviral sequences, but not XMRV, in 86.5% of CFS patients [18]. Claims were made that such findings supported the association of XMRV infection with CFS, complicating an already controversial field. Several factors were speculatively proposed to contribute to the differential detection of XMRV/MLVs by different laboratories. It was suggested that inconsistencies in detection of XMRV/MLVs in patient samples could result from varied prevalence of infection in different populations, differing criteria for patient selection, and differing detection methodologies utilized [19]. It was also proposed that virus levels may be chronically low or episodic in patient plasma or tissues, making virus detection difficult [19]. Adding to the Rabbit Polyclonal to PKC zeta (phospho-Thr410) complexity, detection of XMRV by PCR is highly MC-976 susceptible to false positive results due to the very close genetic relationship of XMRV with endogenous MLVs and the high prevalence of contaminating mouse genomic DNA in many specimens [20,21]. Indeed, studies have suggested that XMRV detection is the result of laboratory contamination from infected cell lines [2225] or contaminated reagents [26]. Further suggestions of laboratory contamination came after publication of a study by Paprotka et al. [25], showing that XMRV originated in a human cancer cell line generated by passaging prostate cancer cells through immunocompromised mice. This result indicates that XMRV could not have entered the human population until recently, yet was already being reported as prevalent in a sizeable fraction of prostatic cancers. Furthermore, it showed that most XMRV-specific detection assays could, in fact, detect one or the other of the two parental proviruses (PreXMRV-1 and 2) that gave rise to XMRV and are endogenous to some inbred and wild mice. In assessing this situation, it became clear that to rule out false positive results and reliably detect XMRV infection, one must apply several diagnostic methods used in conjunction with known positive and negative controls. At the NCI-Frederick, we sought to help clarify the XMRV controversy by generating multiple assays, including rigorous methods to measure antibodies to XMRV through ELISA-based methods, to quantify XMRV proviral DNA and viral RNA through quantitative PCR and.